A detailed history of Optiver Holding B.V. transactions in Galapagos Nv stock. As of the latest transaction made, Optiver Holding B.V. holds 69,396 shares of GLPG stock, worth $1.86 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
69,396
Previous 7,948 773.13%
Holding current value
$1.86 Million
Previous $196,000 918.88%
% of portfolio
0.05%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$24.2 - $30.67 $1.49 Million - $1.88 Million
61,448 Added 773.13%
69,396 $2 Million
Q2 2024

Aug 14, 2024

BUY
$24.78 - $32.48 $146,499 - $192,021
5,912 Added 290.37%
7,948 $196,000
Q1 2024

May 09, 2024

SELL
$32.2 - $42.44 $1.54 Million - $2.03 Million
-47,924 Reduced 95.92%
2,036 $65,000
Q4 2023

Feb 13, 2024

BUY
$31.87 - $40.71 $1.59 Million - $2.03 Million
49,960 New
49,960 $2.03 Million
Q1 2023

May 11, 2023

SELL
$36.5 - $48.0 $1.26 Million - $1.65 Million
-34,460 Reduced 93.88%
2,246 $86,000
Q4 2022

Feb 10, 2023

SELL
$37.44 - $46.51 $2.52 Million - $3.14 Million
-67,407 Reduced 64.74%
36,706 $1.63 Million
Q3 2022

Nov 14, 2022

SELL
$42.27 - $57.6 $8.77 Million - $11.9 Million
-207,440 Reduced 66.58%
104,113 $4.44 Million
Q2 2022

Aug 10, 2022

BUY
$52.3 - $71.59 $15.7 Million - $21.5 Million
300,094 Added 2618.85%
311,553 $17.4 Million
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $1.06 Million - $1.42 Million
-20,747 Reduced 64.42%
11,459 $711,000
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $289,187 - $351,230
6,149 Added 23.6%
32,206 $1.78 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $591,399 - $795,787
11,336 Added 77.01%
26,057 $1.37 Million
Q2 2021

Aug 16, 2021

SELL
$68.86 - $83.34 $6.06 Million - $7.34 Million
-88,039 Reduced 85.67%
14,721 $1.01 Million
Q1 2021

May 14, 2021

BUY
$76.15 - $111.94 $7.83 Million - $11.5 Million
102,760 New
102,760 $7.95 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.